AXSM
Axsome Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$13.13B
P/E Ratio
—
EPS
$-3.73
Beta
0.60
52W High
$257.93
52W Low
$96.09
50-Day MA
$209.80
200-Day MA
$164.86
Dividend Yield
—
Profit Margin
-26.60%
Forward P/E
333.33
PEG Ratio
0.00
About Axsome Therapeutics Inc
Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $708.24M |
| Gross Profit (TTM) | $655.82M |
| EBITDA | $-167.23M |
| Operating Margin | -32.80% |
| Return on Equity | -349.40% |
| Return on Assets | -16.80% |
| Revenue/Share (TTM) | $14.07 |
| Book Value | $1.06 |
| Price-to-Book | 239.23 |
| Price-to-Sales (TTM) | 18.55 |
| EV/Revenue | 18.32 |
| EV/EBITDA | -14.81 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 57.40% |
| Shares Outstanding | $51.46M |
| Float | $43.56M |
| % Insiders | 15.34% |
| % Institutions | 76.52% |
Historical Volatility
HV 10-Day
42.44%
HV 20-Day
32.24%
HV 30-Day
38.84%
HV 60-Day
42.81%
HV Rank
76.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($275.28 target)
3
Strong Buy17
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026